New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 9, 2012
12:08 EDTPCLN, ARNA Stocks with call strike movement; PCLN ARNA
Priceline.com (PCLN) May 800 call volatility increased 9%, Arena Pharmaceuticals (ARNA) May 3 call volatility increased 4% according to iVolatility.
News For PCLN;ARNA From The Last 14 Days
Check below for free stories on PCLN;ARNA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 25, 2014
11:06 EDTPCLNZillow, Trulia continue climb after takeover talks report seen as 'credible'
Subscribe for More Information
08:18 EDTPCLNZillow, Trulia merger story viewed as credible at Deutsche Bank
Deutsche Bank views Bloomberg's report of merger talks between Zillow (Z) and Trulia (TRLA) as credible, saying the deal would make a lot of sense. The firm says Trulia shares would be worth around $63 in a takeover when using Priceline's (PCLN) acquisition of OpenTable as a comparison. Even at that price, the firm sees nearly 20% upside for Zillow's enterprise value should an acquisition occur. Deutsche notes that neither company has denied yesterday's report, nor has either company announced an earnings date. It cautions, though, that the potential merger could easily fall apart as well. It has a Buy rating on Trulia and Hold rating on Zillow.
July 24, 2014
08:23 EDTPCLNPriceline completes OpenTable tender offer
Subscribe for More Information
July 23, 2014
11:24 EDTPCLNIndustry data points to strong Q2 for online travel names, says Piper Jaffray
Subscribe for More Information
July 21, 2014
08:11 EDTARNAArena Pharma' subsidiary enters into agreement for Belviq with Teva subsidiary
Subscribe for More Information
July 16, 2014
18:03 EDTPCLNMedAssets to replace OpenTable in S&P 600 as of 7/23 close
Subscribe for More Information
09:37 EDTARNAActive equity options trading on open
Subscribe for More Information
July 15, 2014
16:34 EDTARNAArena Pharmaceuticals granted patent for Cannabinoid Receptor Modulators
Arena Pharmaceuticals announced that it was granted U.S. Patent No. 8,778,950, entitled "Cannabinoid Receptor Modulators," by the U.S. Patent and Trademark Office for APD371, an agonist of the cannabinoid receptor 2. Arena is exploring several potential indications for APD371, including chronic pain, and is currently conducting a Phase 1 single-ascending dose trial.
10:40 EDTARNAArena Pharmaceuticals receives USPTO patent for cannabinoid receptor modulators
Reference Link
July 11, 2014
06:10 EDTPCLNJPMorgan expects solid Q2 results in Internet space
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use